CEMIPLIMAB
UNII 6QVL057INT

Substance Identification & Data

This profile provides standardized clinical and technical data for Cemiplimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6QVL057INT.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1801342-60-8 and the RxNorm Concept ID (RxCUI) 2058826. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6QVL057INT

CAS Registry Number

1801342-60-8

RxNorm Concept ID

2058826

Detailed Substance Profile

Preferred Name

CEMIPLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

6QVL057INT

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C121540

National Cancer Institute reference terminology for clinical and research data.

INN ID

10691

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

DE-88

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cemiplimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CEMIPLIMAB

CEMIPLIMAB-RWLC

Common Names & Synonyms

CEMIPLIMAB [INN]

CEMIPLIMAB [JAN]

CEMIPLIMAB [MI]

CEMIPLIMAB [USAN]

CEMIPLIMAB [WHO-DD]

CEMIPLIMAB RWLC [WHO-DD]

CEMIPLIMAB-RWLC [PURPLE BOOK CDER]

IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER